Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome (2020)
- Authors:
- USP affiliated authors: BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM ; VALASSI, HELENA PANTELIOU LIMA - FM ; MENDONÇA, BERENICE BILHARINHO DE - FM ; BARACAT, EDMUND CHADA - FM
- Unidade: FM
- DOI: 10.1210/clinem/dgaa369
- Subjects: BIOMARCADORES; CRIANÇAS; DIAGNÓSTICO DIFERENCIAL; CORTISOL; SÍNDROME DO OVÁRIO POLICÍSTICO; ESTUDOS RETROSPECTIVOS; ESTEROIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2020
- Source:
- Título: Journal of clinical endocrinology & metabolism
- ISSN: 0021-972X
- Volume/Número/Paginação/Ano: v. 105, n. 8, p. E2895-E2902, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MAFFAZIOLI, Giovana D. N et al. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome. Journal of clinical endocrinology & metabolism, v. 105, n. 8, p. E2895-E2902, 2020Tradução . . Disponível em: https://doi.org/10.1210/clinem/dgaa369. Acesso em: 13 fev. 2026. -
APA
Maffazioli, G. D. N., Bachega, T. A. S. S., Hayashida, S. A. Y., Gomes, L. G., Valassi, H. P. L., Marcondes, J. A. M., et al. (2020). Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome. Journal of clinical endocrinology & metabolism, 105( 8), E2895-E2902. doi:10.1210/clinem/dgaa369 -
NLM
Maffazioli GDN, Bachega TASS, Hayashida SAY, Gomes LG, Valassi HPL, Marcondes JAM, Mendonca BB de, Baracat EC, Maciel GAR. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome [Internet]. Journal of clinical endocrinology & metabolism. 2020 ; 105( 8): E2895-E2902.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1210/clinem/dgaa369 -
Vancouver
Maffazioli GDN, Bachega TASS, Hayashida SAY, Gomes LG, Valassi HPL, Marcondes JAM, Mendonca BB de, Baracat EC, Maciel GAR. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome [Internet]. Journal of clinical endocrinology & metabolism. 2020 ; 105( 8): E2895-E2902.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1210/clinem/dgaa369 - Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome
- Validation of an immunoassay for anti-Müllerian hormone measurements and reference intervals in healthy Brazilian subjects
- Análise de um radioimunoensaio iodado para determinação de 11-deoxicortisol
- Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples
- Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome
- Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency
- CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia
- Long Term Glucocorticoid Exposition Does Not Play the Major Role in the Development of Obesity and Metabolic Syndrome in Classical Form of 21-Hydroxylase Deficiency
- The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene
- Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real?
Informações sobre o DOI: 10.1210/clinem/dgaa369 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
